AI System Detects Cancer 5 Years Before Symptoms With 92% Accuracy

Researchers at the Mayo Clinic have developed an AI system that can detect multiple cancer types up to 5 years before symptoms appear using routine blood test data, achieving 92% accuracy in clinical validation.

How It Works

The AI analyzes patterns in standard blood panel results — CBC, metabolic panel, liver enzymes — that are invisible to human doctors but correlate with early-stage cancer development.

Clinical Trial

A 50,000-patient prospective trial begins this summer at 20 medical centers. If validated, the test could be added to annual physical exams as a standard cancer screening tool.

• Detects cancer up to 5 years early
• 92% accuracy in clinical validation
• Uses standard blood test data
• 50,000-patient trial starting summer 2026